Cargando…

Utility of Wavelet Denoising with Geometry Factor Weighting for Gadoxetic Acid-enhanced Hepatobiliary-phase MR Imaging

Purpose: The wavelet denoising with geometry factor weighting (g-denoising) method can reduce the image noise by adapting to spatially varying noise levels induced by parallel imaging. The aim of this study was to investigate the clinical applicability of g-denoising on hepatobiliary-phase (HBP) ima...

Descripción completa

Detalles Bibliográficos
Autores principales: Kondo, Shota, Nakamura, Yuko, Higaki, Toru, Nishihara, Takashi, Takizawa, Masahiro, Shirai, Toru, Fujimori, Motoshi, Bito, Yoshitaka, Narita, Keigo, Sueoka, Takahiro, Honda, Yukiko, Tani, Chihiro, Awai, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Magnetic Resonance in Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086400/
https://www.ncbi.nlm.nih.gov/pubmed/35650028
http://dx.doi.org/10.2463/mrms.mp.2022-0041
_version_ 1785022144434929664
author Kondo, Shota
Nakamura, Yuko
Higaki, Toru
Nishihara, Takashi
Takizawa, Masahiro
Shirai, Toru
Fujimori, Motoshi
Bito, Yoshitaka
Narita, Keigo
Sueoka, Takahiro
Honda, Yukiko
Tani, Chihiro
Awai, Kazuo
author_facet Kondo, Shota
Nakamura, Yuko
Higaki, Toru
Nishihara, Takashi
Takizawa, Masahiro
Shirai, Toru
Fujimori, Motoshi
Bito, Yoshitaka
Narita, Keigo
Sueoka, Takahiro
Honda, Yukiko
Tani, Chihiro
Awai, Kazuo
author_sort Kondo, Shota
collection PubMed
description Purpose: The wavelet denoising with geometry factor weighting (g-denoising) method can reduce the image noise by adapting to spatially varying noise levels induced by parallel imaging. The aim of this study was to investigate the clinical applicability of g-denoising on hepatobiliary-phase (HBP) images with gadoxetic acid. Methods: We subjected 53 patients suspected of harboring hepatic neoplastic lesions to gadoxetic acid-enhanced HBP imaging with and without g-denoising (g(+)HBP and g(–)HBP). The matrix size was reduced for g(+)HBP images to avoid prolonging the scanning time. Two radiologists calculated the SNR, the portal vein-, and paraspinal muscle contrast-to-noise ratio (CNR) relative to the hepatic parenchyma (liver-to-portal vein- and liver-to-muscle CNR). Two other radiologists independently graded the sharpness of the liver edge, the visibility of intrahepatic vessels, the image noise, the homogeneity of liver parenchyma, and the overall image quality using a 5-point scale. Differences between g(–)HBP and g(+)HBP images were determined with the two-sided Wilcoxon signed-rank test. Results: The liver-to-portal- and liver-to-muscle CNR and the SNR were significantly higher on g(+)HBP- than g(–)HBP images (P < 0.01), as was the qualitative score for the image noise, homogeneity of liver parenchyma, and overall image quality (P < 0.01). Although there were no significant differences in the scores for the sharpness of the liver edge or the score assigned for the visibility of intrahepatic vessels (P = 0.05, 0.43), with g(+)HBP the score was lower in three patients for the sharpness of the liver edge and in six patients for the visibility of intrahepatic vessels. Conclusion: At gadoxetic acid-enhanced HBP imaging, g-denoising yielded a better image quality than conventional HBP imaging although the anatomic details may be degraded.
format Online
Article
Text
id pubmed-10086400
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Japanese Society for Magnetic Resonance in Medicine
record_format MEDLINE/PubMed
spelling pubmed-100864002023-04-12 Utility of Wavelet Denoising with Geometry Factor Weighting for Gadoxetic Acid-enhanced Hepatobiliary-phase MR Imaging Kondo, Shota Nakamura, Yuko Higaki, Toru Nishihara, Takashi Takizawa, Masahiro Shirai, Toru Fujimori, Motoshi Bito, Yoshitaka Narita, Keigo Sueoka, Takahiro Honda, Yukiko Tani, Chihiro Awai, Kazuo Magn Reson Med Sci Major Paper Purpose: The wavelet denoising with geometry factor weighting (g-denoising) method can reduce the image noise by adapting to spatially varying noise levels induced by parallel imaging. The aim of this study was to investigate the clinical applicability of g-denoising on hepatobiliary-phase (HBP) images with gadoxetic acid. Methods: We subjected 53 patients suspected of harboring hepatic neoplastic lesions to gadoxetic acid-enhanced HBP imaging with and without g-denoising (g(+)HBP and g(–)HBP). The matrix size was reduced for g(+)HBP images to avoid prolonging the scanning time. Two radiologists calculated the SNR, the portal vein-, and paraspinal muscle contrast-to-noise ratio (CNR) relative to the hepatic parenchyma (liver-to-portal vein- and liver-to-muscle CNR). Two other radiologists independently graded the sharpness of the liver edge, the visibility of intrahepatic vessels, the image noise, the homogeneity of liver parenchyma, and the overall image quality using a 5-point scale. Differences between g(–)HBP and g(+)HBP images were determined with the two-sided Wilcoxon signed-rank test. Results: The liver-to-portal- and liver-to-muscle CNR and the SNR were significantly higher on g(+)HBP- than g(–)HBP images (P < 0.01), as was the qualitative score for the image noise, homogeneity of liver parenchyma, and overall image quality (P < 0.01). Although there were no significant differences in the scores for the sharpness of the liver edge or the score assigned for the visibility of intrahepatic vessels (P = 0.05, 0.43), with g(+)HBP the score was lower in three patients for the sharpness of the liver edge and in six patients for the visibility of intrahepatic vessels. Conclusion: At gadoxetic acid-enhanced HBP imaging, g-denoising yielded a better image quality than conventional HBP imaging although the anatomic details may be degraded. Japanese Society for Magnetic Resonance in Medicine 2022-06-01 /pmc/articles/PMC10086400/ /pubmed/35650028 http://dx.doi.org/10.2463/mrms.mp.2022-0041 Text en ©2022 Japanese Society for Magnetic Resonance in Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Major Paper
Kondo, Shota
Nakamura, Yuko
Higaki, Toru
Nishihara, Takashi
Takizawa, Masahiro
Shirai, Toru
Fujimori, Motoshi
Bito, Yoshitaka
Narita, Keigo
Sueoka, Takahiro
Honda, Yukiko
Tani, Chihiro
Awai, Kazuo
Utility of Wavelet Denoising with Geometry Factor Weighting for Gadoxetic Acid-enhanced Hepatobiliary-phase MR Imaging
title Utility of Wavelet Denoising with Geometry Factor Weighting for Gadoxetic Acid-enhanced Hepatobiliary-phase MR Imaging
title_full Utility of Wavelet Denoising with Geometry Factor Weighting for Gadoxetic Acid-enhanced Hepatobiliary-phase MR Imaging
title_fullStr Utility of Wavelet Denoising with Geometry Factor Weighting for Gadoxetic Acid-enhanced Hepatobiliary-phase MR Imaging
title_full_unstemmed Utility of Wavelet Denoising with Geometry Factor Weighting for Gadoxetic Acid-enhanced Hepatobiliary-phase MR Imaging
title_short Utility of Wavelet Denoising with Geometry Factor Weighting for Gadoxetic Acid-enhanced Hepatobiliary-phase MR Imaging
title_sort utility of wavelet denoising with geometry factor weighting for gadoxetic acid-enhanced hepatobiliary-phase mr imaging
topic Major Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086400/
https://www.ncbi.nlm.nih.gov/pubmed/35650028
http://dx.doi.org/10.2463/mrms.mp.2022-0041
work_keys_str_mv AT kondoshota utilityofwaveletdenoisingwithgeometryfactorweightingforgadoxeticacidenhancedhepatobiliaryphasemrimaging
AT nakamurayuko utilityofwaveletdenoisingwithgeometryfactorweightingforgadoxeticacidenhancedhepatobiliaryphasemrimaging
AT higakitoru utilityofwaveletdenoisingwithgeometryfactorweightingforgadoxeticacidenhancedhepatobiliaryphasemrimaging
AT nishiharatakashi utilityofwaveletdenoisingwithgeometryfactorweightingforgadoxeticacidenhancedhepatobiliaryphasemrimaging
AT takizawamasahiro utilityofwaveletdenoisingwithgeometryfactorweightingforgadoxeticacidenhancedhepatobiliaryphasemrimaging
AT shiraitoru utilityofwaveletdenoisingwithgeometryfactorweightingforgadoxeticacidenhancedhepatobiliaryphasemrimaging
AT fujimorimotoshi utilityofwaveletdenoisingwithgeometryfactorweightingforgadoxeticacidenhancedhepatobiliaryphasemrimaging
AT bitoyoshitaka utilityofwaveletdenoisingwithgeometryfactorweightingforgadoxeticacidenhancedhepatobiliaryphasemrimaging
AT naritakeigo utilityofwaveletdenoisingwithgeometryfactorweightingforgadoxeticacidenhancedhepatobiliaryphasemrimaging
AT sueokatakahiro utilityofwaveletdenoisingwithgeometryfactorweightingforgadoxeticacidenhancedhepatobiliaryphasemrimaging
AT hondayukiko utilityofwaveletdenoisingwithgeometryfactorweightingforgadoxeticacidenhancedhepatobiliaryphasemrimaging
AT tanichihiro utilityofwaveletdenoisingwithgeometryfactorweightingforgadoxeticacidenhancedhepatobiliaryphasemrimaging
AT awaikazuo utilityofwaveletdenoisingwithgeometryfactorweightingforgadoxeticacidenhancedhepatobiliaryphasemrimaging